A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients with Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
Kathleen Dorris
Study ID
Protocol Number: 22-0490
More information available at ClinicalTrials.gov: NCT04978727
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers